Bioventus Inc (BVS)
11.71
+0.20
(+1.74%)
USD |
NASDAQ |
Nov 22, 16:00
11.76
+0.05
(+0.43%)
After-Hours: 20:00
Bioventus Cash from Investing (Quarterly): -0.064M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.064M |
| June 30, 2024 | -0.077M |
| March 31, 2024 | -1.00M |
| December 31, 2023 | -0.591M |
| September 30, 2023 | -2.036M |
| June 30, 2023 | 33.50M |
| March 31, 2023 | -15.07M |
| December 31, 2022 | -3.403M |
| September 30, 2022 | -56.33M |
| June 30, 2022 | -52.02M |
| March 31, 2022 | -4.674M |
| Date | Value |
|---|---|
| December 31, 2021 | -221.28M |
| September 30, 2021 | -13.19M |
| June 30, 2021 | -2.648M |
| March 31, 2021 | -46.65M |
| December 31, 2020 | -1.711M |
| September 30, 2020 | -17.76M |
| June 30, 2020 | -0.579M |
| March 31, 2020 | -0.451M |
| March 31, 2016 | -6.638M |
| March 31, 2015 | -0.306M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-221.28M
Minimum
Dec 2021
33.50M
Maximum
Jun 2023
-21.37M
Average
-2.648M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Insulet Corp | -29.30M |
| Perspective Therapeutics Inc | -29.74M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.32M |
| Cash from Financing (Quarterly) | 0.362M |
| Free Cash Flow | 29.05M |
| Free Cash Flow Per Share (Quarterly) | 0.1571 |
| Free Cash Flow to Equity (Quarterly) | 9.947M |
| Free Cash Flow to Firm (Quarterly) | 20.95M |
| Free Cash Flow Yield | 3.88% |